Januvia
Januvia is a diabetes medication containing Sitagliptin, available as 50/100mg tablets.
- Category
- Diabetes
- Active ingredient
- Sitagliptin
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 50/100mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Januvia vary by country.
Details
- Conditions
- Type 2 diabetes mellitus
- Alternative Name
- Xelevia
- Therapeutic Class
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
- Pharmacological Class
- DPP-4 Inhibitor
- Minor Side Effects
- nausea, upper respiratory tract infection
- Moderate Side Effects
- hypoglycaemia when combined with insulin or sulphonylureas, constipation
- Dosage Forms
- Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Originator
- Merck Sharp & Dohme
- Onset Time
- 1–4 hours
- Duration
- 24 hours
- Storage Instructions
- Store below 30°C in the original container.
- Drug Interactions
- digoxin
- Age Restrictions
- Not indicated for patients under 18 years.
What you will receive
Januvia is the originator brand name, made by Merck Sharp & Dohme. We use it here to identify the medicine only; we are not affiliated with Merck Sharp & Dohme and do not ship the original Januvia.
- You receive a generic equivalent: the same active ingredient (Sitagliptin) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.